Silver Book Fact

A study exploring the decline in deaths attributable to cardiovascular disease in the U.S. from 1980 to 2000 suggested that approximately 47% of the decrease was due to the increased use of evidence-based medical therapies. 44% was due to changes in the risk factors of the population attributable to lifestyle and environmental changes.

Ford E, Ajani U, Croft J, Critchely J, et al. Explaining the Decrease in US Deaths from Coronary Disease, 1980-2000. N Engl J Med. 2007; 356: 2388-98. http://www.nejm.org/doi/full/10.1056/NEJMsa053935

Reference

Title
Explaining the Decrease in US Deaths from Coronary Disease, 1980-2000
Publication
N Engl J Med
Publication Date
2007
Authors
Ford E, Ajani U, Croft J, Critchely J, et al.
Pages
2388-98
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Aspirin use in AFib patients
    Meta-analysis of a number of randomized controlled trials found that aspirin use in atrial fibrillation patients reduced stroke risk by an average 22%.  
  • Since 1950, reduction in heart disease mortality has added more than 3 1/2 years to the expected lifetimes of both men and women.  
  • Several prevention/early detection interventions for cardiovascular disease have cost-effectiveness ratios of $50,000-$70,000 per life saved.  
  • Satisfaction rates of heart valve disease patients with their treatment
     
  • Every additional dollar spent on the routine use of beta-blockers (versus under-use) in acute heart attack patients has produced health gains valued as high as $38.44.